HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 10-16-2007, 12:33 PM   #1
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
we all know where you are treated for bc is important

but here is evidence from Medicare records that even just for the usual illnesses that bring people to hospitals, there is an enormous difference in the results in hospitals...

Mortality rates 71 percent lower at top-rated hospitals: HealthGrades 2008 hospital-quality study [Eureka News Service]
GOLDEN, Colo. (October 15, 2007) - Patients have on average a 71 percent lower chance of dying at the nation's top-rated hospitals compared with the lowest-rated hospitals across 18 procedures and conditions analyzed in the tenth annual HealthGrades Hospital Quality in America Study, issued today by HealthGrades, the healthcare ratings company. The study, which documents a wide variation in the quality of care between the highest-performing hospitals and all others, also found that if all hospitals performed at the level of hospitals rated with five stars by HealthGrades, 266,604 Medicare lives could potentially have been saved over the three years studied.
The HealthGrades study of patient outcomes at the nation's approximately 5,000 hospitals, the most comprehensive annual study of its kind, covers more than 41 million Medicare hospitalization records over the years 2004 to 2006. The study examines procedures and conditions ranging from heart attack to pneumonia to valve-replacement surgery. Based on the study, HealthGrades today made available its 2008 quality ratings for virtually every hospital in the country at www.healthgrades.com, a Web site designed to help individuals research and compare local healthcare providers.
According to the study, mortality rates at America's hospitals have improved 11.8 percent from 2004 to 2006, with the nation's top-rated hospitals improving at a faster rate (12.8 percent) than the lowest rated hospitals (11.4 percent). Of the 18 procedures and conditions studied, those that saw the most improvement in mortality rates were pancreatitis (19.2 percent), pulmonary embolism (17.4 percent) and diabetic acidosis and coma (16.6 percent). Those with the smallest improvement were resection/replacement of the abdominal aorta (0.4 percent), coronary interventional procedures such as angioplasties and stents (0.8 percent) and treatment of heart attack (8.9 percent).
Full reports on mortality rate trends in each of the 50 states and the District of Columbia are available in the study.
"While we are pleased to see that the hospital industry's focus on improving care quality has continued to reduce mortality rates, a significant variation in quality among the nation's best and poorest-performing hospitals persists," said Samantha Collier, MD, HealthGrades' chief medical officer and one of the authors of the study. "Concentrating on emulating practices from exemplary hospitals can result in improvement. If this focus were targeted to four key quality areas — heart failure, respiratory failure, sepsis, and pneumonia — the nation could achieve up to a 50-percent reduction in potentially preventable deaths."
The study also found wide variation in risk-adjusted mortality at the state and regional levels:
Across all procedures and conditions, the average number of states performing statistically significantly better than predicted was 14, while an average of 19 states performed statistically significantly worse than predicted.
The region with the lowest overall risk-adjusted mortality was the East North Central Region (IL, IN, MI, OH and WI) while the East South Central region (AL, KY, MS and TN) had the highest mortality.
The region with the most overall improvement for all procedures and conditions was the West South Central region (AR, LA, OK and TX), where the risk-adjusted mortality dropped by 13.5 percent. The least improvement was seen in the Mountain region (AZ, CO, ID, MT, NE, NV, NM, UT, and WY), with a decline of 8.8 percent.
The East North Central region (IL, IN, MI, OH, and WI), had the highest percentage of best-performing hospitals - those hospitals that are among the best 15 percent for risk-adjusted mortality overall - at 26 percent.
Less than seven percent of hospitals within the East South Central region (AL, KY, MS, and TN) and the New England region (CT, ME, MA, NH, RI, and VT) were top-performing hospitals.
In the study's analysis of mortality rates, the following 18 procedures and conditions were analyzed: atrial fibrillation, bowel obstruction, chronic obstructive pulmonary disease, coronary bypass surgery, coronary interventional procedures (angioplasty/stent), diabetic acidosis and coma, gastrointestinal bleed, gastrointestinal surgeries and procedures, heart attack, heart failure, pancreatitis, pneumonia, pulmonary embolism, resection/replacement of the abdominal aorta, respiratory failure, sepsis, stroke, and valve replacement surgery.
---
Lani is offline   Reply With Quote
Old 10-16-2007, 12:45 PM   #2
hutchibk
Senior Member
 
hutchibk's Avatar
 
Join Date: Oct 2005
Posts: 3,519
I feel very lucky to be in the West South Central region...
__________________
Brenda

NOV 2012 - 9 yr anniversary
JULY 2012 - 7 yr anniversary stage IV (of 50...)

Nov'03~ dX stage 2B
Dec'03~
Rt side mastectomy, Her2+, ER/PR+, 10 nodes out, one node positive
Jan'04~
Taxotere/Adria/Cytoxan x 6, NED, no Rads, Tamox. 1 year, Arimadex 3 mo., NED 14 mo.
Sept'05~
micro mets lungs/chest nodes/underarm node, Switched to Aromasin, T/C/H x 7, NED 6 months - Herceptin only
Aug'06~
micro mets chest nodes, & bone spot @ C3 neck, Added Taxol to Herceptin
Feb'07~ Genetic testing, BRCA 1&2 neg

Apr'07~
MRI - two 9mm brain mets & 5 punctates, new left chest met, & small increase of bone spot C3 neck, Stopped Aromasin
May'07~
Started Tykerb/Xeloda, no WBR for now
June'07~
MRI - stable brain mets, no new mets, 9mm spots less enhanced, CA15.3 down 45.5 to 9.3 in 10 wks, Ty/Xel working magic!
Aug'07~
MRI - brain mets shrunk half, NO NEW BRAIN METS!!, TMs stable @ 9.2
Oct'07~
PET/CT & MRI show NED
Apr'08~
scans still show NED in the head, small bone spot on right iliac crest (rear pelvic bone)
Sept'08~
MRI shows activity in brain mets, completed 5 fractions/5 consecutive days of IMRT to zap the pesky buggers
Oct'08~
dropped Xeloda, switched to tri-weekly Herceptin in combo with Tykerb, extend to tri-monthly Zometa infusion
Dec'08~
Brain MRI- 4 spots reduced to punctate size, large spot shrunk by 3mm, CT of torso clear/pelvis spot stable
June'09~
new 3-4mm left cerrebellar spot zapped with IMRT targeted rads
Sept'09~
new 6mm & 1 cm spots in pituitary/optic chiasm area. Rx= 25 days of 3D conformal fractionated targeted IMRT to the tumors.
Oct'09~
25 days of low dose 3D conformal fractionated targeted IMRT to the bone mets spot on rt. iliac crest that have been watching for 2 years. Added daily Aromasin back into treatment regimen.
Apr'10~ Brain MRI clear! But, see new small spot on adrenal gland. Change from Aromasin back to Tamoxifen.
June'10~ Tumor markers (CA15.3) dropped from 37 to 23 after one month on Tamoxifen. Continue to monitor adrenal gland spot. Remain on Tykerb/Herceptin/Tamoxifen.
Nov'10~ Radiate positive mediastinal node that was pressing on recurrent laryngeal nerve, causing paralyzed larynx and a funny voice.
Jan'11~ MRI shows possible activity or perhaps just scar tissue/necrotic increase on 3 previously treated brain spots and a pituitary spot. 5 days of IMRT on 4 spots.
Feb'11~ Enrolled in T-DM1 EAP in Denver, first treatment March 25, 2011.
Mar'11~ Finally started T-DM1 EAP in Denver at Rocky Mountain Cancer Center/Rose on Mar. 25... hallelujah.

"I would rather be anecdotally alive than statistically dead."
hutchibk is offline   Reply With Quote
Old 10-16-2007, 02:11 PM   #3
Grace
Guest
 
Posts: n/a
And I left my major cancer center in NYC for Downeast Maine! Oh well, the people are nicer, the lobster is cheaper, and the sunsets better.
  Reply With Quote
Old 10-16-2007, 03:13 PM   #4
KellyA
Senior Member
 
KellyA's Avatar
 
Join Date: Sep 2006
Location: Savannah, Georgia
Posts: 301
Good grief, Georgia's so lousy its not even mentioned. I guess we are in that bad catagory with TN, and KY.

Kelly
__________________
dx'd 05/06, 37 years old
er/pr-, Her2+, grade 3
double mastectomy, immediate reconstruction- implants
Stage 2b, 2 tumors- 2.2 cm and 0.6 cm, 3/5 + nodes
all scans clear
genetic testing- negative
06/06 began dd A/C x 4, 12 weekly Taxols w/ Herceptin
30 rads
Herceptin weekly x 1 year
Herceptin completed 08/07
Port removed 12/26/07 MERRY CHRISTMAS!!!!!!
05/17/08 Two year anniversary NED

"We gain strength, courage, and confidence by each experience in which we really stop to look fear in the face... you must do the thing that you think you cannot do."

-Eleanor Roosevelt

KellyA is offline   Reply With Quote
Old 10-16-2007, 03:17 PM   #5
Soccermom
Senior Member
 
Soccermom's Avatar
 
Join Date: Jun 2006
Location: Bradenton,FL
Posts: 977
Just what I needed to hear...sigh...oh well, back to MD Anderson...
Marcia
Soccermom is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 01:50 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter